6581 - 6590 of 9034 Results
Title
Year
- Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo2017RESTRICTEDTitle: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivoJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 123Issue #:Start Page: 34End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011Citation Count: 12
-
OPENTitle: Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 26537End Page: 26537Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-10705-8Best OA location URL: https://www.nature.com/articles/s41598-025-10705-8.pdfCitation Count: 4
-
OPENTitle: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmosetJournal Name: European Journal of NeurosciencePublisher: WileyVol: 60Issue #: 9Start Page: 6175End Page: 6184Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16454Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16454Citation Count: 3
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile2008RESTRICTEDTitle: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profileJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 16Start Page: 2398End Page: 2403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22341Citation Count: 248
- Conversational analysis of consciousness during seizures2020RESTRICTEDTitle: Conversational analysis of consciousness during seizuresJournal Name: Epilepsy & BehaviorPublisher: Elsevier BVVol: 112Issue #:Start Page: 107486End Page: 107486Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.yebeh.2020.107486Citation Count: 4
-
OPENTitle: 17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/969418Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/969418.pdfCitation Count: 12
-
OPENTitle: Defining Quality of Life: The Perspective of People Living with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70517Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70517Citation Count: 0
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 16
- Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disorders2012RESTRICTEDTitle: Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 5Start Page: 548End Page: 552Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.02.009Citation Count: 72